1. Home
  2. STOK vs NSSC Comparison

STOK vs NSSC Comparison

Compare STOK & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.15

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$36.56

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
NSSC
Founded
2014
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
STOK
NSSC
Price
$31.15
$36.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
6
Target Price
$39.20
$48.17
AVG Volume (30 Days)
478.9K
378.6K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
1.33%
EPS Growth
92.73
N/A
EPS
N/A
0.70
Revenue
$184,420,000.00
$181,621,000.00
Revenue This Year
N/A
$13.63
Revenue Next Year
$77.49
$10.05
P/E Ratio
N/A
$51.91
Revenue Growth
404.50
N/A
52 Week Low
$9.36
$26.44
52 Week High
$40.22
$47.61

Technical Indicators

Market Signals
Indicator
STOK
NSSC
Relative Strength Index (RSI) 46.40 37.09
Support Level $30.34 $35.89
Resistance Level $35.11 $44.43
Average True Range (ATR) 1.54 1.33
MACD 0.07 -0.12
Stochastic Oscillator 51.03 22.51

Price Performance

Historical Comparison
STOK
NSSC

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: